Frankfurt - Delayed Quote EUR

Amplitude Surgical SA (1AU.F)

2.7800 -0.0400 (-1.42%)
At close: May 31 at 8:07 AM GMT+2
Loading Chart for 1AU.F
DELL
  • Previous Close 2.8200
  • Open 2.7800
  • Bid 2.8400 x 100000
  • Ask 3.0000 x 100000
  • Day's Range 2.7800 - 2.7800
  • 52 Week Range 2.6200 - 3.5400
  • Volume 500
  • Avg. Volume 8
  • Market Cap (intraday) 140.125M
  • Beta (5Y Monthly) 0.53
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0600
  • Earnings Date Mar 20, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Amplitude Surgical SA develops and markets products for orthopedic surgery. The company provides a range of orthopedic products for primary and revision surgery aimed at treating pathologies of the hip, knee, and lower extremities primarily for foot and ankle surgery. It also offers AMPLIVISION, a computer-assisted surgical system; the i.M.A.G.E., a single-use made-to-measure instrument system; and E.T.O.I.L.E, a technology platform for anterior approaches resulting in less-invasive surgery. In addition, the company provides instruments for fitting related accessories. It sells its products through a network of distributors and agents in approximately 30 countries. The company serves patients, surgeons, and healthcare facilities. Amplitude Surgical SA was founded in 1997 and is headquartered in Valence, France. As of January 21, 2021, Amplitude Surgical SA operates as a subsidiary of PAI Partners.

www.amplitude-surgical.com

416

Full Time Employees

June 30

Fiscal Year Ends

Recent News: 1AU.F

Performance Overview: 1AU.F

Trailing total returns as of 5/31/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

1AU.F
13.13%
CAC 40
5.96%

1-Year Return

1AU.F
15.24%
CAC 40
10.86%

3-Year Return

1AU.F
28.70%
CAC 40
23.27%

5-Year Return

1AU.F
17.80%
CAC 40
52.28%

Compare To: 1AU.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 1AU.F

Valuation Measures

Annual
As of 5/31/2024
  • Market Cap

    140.13M

  • Enterprise Value

    221.64M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.28

  • Price/Book (mrq)

    1.41

  • Enterprise Value/Revenue

    2.13

  • Enterprise Value/EBITDA

    10.75

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    41.54%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    104.1M

  • Net Income Avi to Common (ttm)

    -2.95M

  • Diluted EPS (ttm)

    -0.0600

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: 1AU.F

Company Insights: 1AU.F

Research Reports: 1AU.F